Skip to main content
. 2021 Jul 20;11:706337. doi: 10.3389/fonc.2021.706337

Figure 5.

Figure 5

The G6PD inhibitor polydatin suppresses ESCC cell proliferation. G6PD activity (A) and cellular NADPH concentration (B) decreased in a dose-dependent manner upon polydatin treatment. ESCC cell proliferation after polydatin treatment was assessed by colony formation assay (C) and EdU incorporation assay (D). *P < 0.05, **P < 0.01, ***P < 0.001.